Cargando…

Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction

BACKGROUND: Moderate aortic stenosis (MAS) has not been extensively studied and characterized, as no published study has been specifically devoted to this condition. METHODS AND RESULTS: We aimed to describe the characteristics of patients with MAS and to evaluate their long‐term survival compared w...

Descripción completa

Detalles Bibliográficos
Autores principales: Delesalle, Geraud, Bohbot, Yohann, Rusinaru, Dan, Delpierre, Quentin, Maréchaux, Sylvestre, Tribouilloy, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475062/
https://www.ncbi.nlm.nih.gov/pubmed/30841771
http://dx.doi.org/10.1161/JAHA.118.011036
_version_ 1783412705260994560
author Delesalle, Geraud
Bohbot, Yohann
Rusinaru, Dan
Delpierre, Quentin
Maréchaux, Sylvestre
Tribouilloy, Christophe
author_facet Delesalle, Geraud
Bohbot, Yohann
Rusinaru, Dan
Delpierre, Quentin
Maréchaux, Sylvestre
Tribouilloy, Christophe
author_sort Delesalle, Geraud
collection PubMed
description BACKGROUND: Moderate aortic stenosis (MAS) has not been extensively studied and characterized, as no published study has been specifically devoted to this condition. METHODS AND RESULTS: We aimed to describe the characteristics of patients with MAS and to evaluate their long‐term survival compared with that of the general population. This study included 508 patients (mean±SD age, 75±11 years) with MAS (aortic valve area between 1 and 1.5 cm(2); mean±SD aortic valve area, 1.2±0.15 cm(2)) and preserved left ventricular ejection fraction. Patients were mostly (86.4%) asymptomatic or minimally symptomatic, 78.3% had hypertension, 36.2% were diabetics, and 48.3% had dyslipidemia. Each patient with MAS was matched for the average survival (per year) of all patients of the same age and same sex from our region (Somme department, north of France). During follow‐up (median 47 months), 113 patients (22.2%) underwent aortic valve replacement for severe AS. The mean±SD time between inclusion and surgery was 37±22 months. During follow‐up, 255 patients (50.2%) died. The 6‐year survival of patients with MAS was lower than the expected survival (53±2% versus 65%). In multivariate analysis, age (hazard ratio, 1.04 [95% CI, 1.02–1.05]; P<0.001), prior atrial fibrillation (hazard ratio, 1.35 [95% CI, 1.05–1.73]; P=0.019), and Charlson comorbidity index (hazard ratio, 1.11 [95% CI, 1.05–1.18]; P=0.002) were associated with increased mortality. Aortic valve replacement was associated with better survival (hazard ratio, 0.38 [95% CI, 0.27–0.54]; P<0.001). CONCLUSIONS: The results of this study show that patients with MAS present many cardiovascular risk factors, a high rate of surgery during follow‐up, and increased mortality compared with the general population mainly related to associated comorbidities. Patients with MAS should, therefore, be managed for their cardiovascular risk factors and comorbidities. They require close follow‐up, especially when the aortic valve area is close to 1 cm(2), as aortic valve replacement performed when patients transition to severe AS and develop indications for surgery during follow‐up is associated with better survival.
format Online
Article
Text
id pubmed-6475062
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64750622019-04-24 Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction Delesalle, Geraud Bohbot, Yohann Rusinaru, Dan Delpierre, Quentin Maréchaux, Sylvestre Tribouilloy, Christophe J Am Heart Assoc Original Research BACKGROUND: Moderate aortic stenosis (MAS) has not been extensively studied and characterized, as no published study has been specifically devoted to this condition. METHODS AND RESULTS: We aimed to describe the characteristics of patients with MAS and to evaluate their long‐term survival compared with that of the general population. This study included 508 patients (mean±SD age, 75±11 years) with MAS (aortic valve area between 1 and 1.5 cm(2); mean±SD aortic valve area, 1.2±0.15 cm(2)) and preserved left ventricular ejection fraction. Patients were mostly (86.4%) asymptomatic or minimally symptomatic, 78.3% had hypertension, 36.2% were diabetics, and 48.3% had dyslipidemia. Each patient with MAS was matched for the average survival (per year) of all patients of the same age and same sex from our region (Somme department, north of France). During follow‐up (median 47 months), 113 patients (22.2%) underwent aortic valve replacement for severe AS. The mean±SD time between inclusion and surgery was 37±22 months. During follow‐up, 255 patients (50.2%) died. The 6‐year survival of patients with MAS was lower than the expected survival (53±2% versus 65%). In multivariate analysis, age (hazard ratio, 1.04 [95% CI, 1.02–1.05]; P<0.001), prior atrial fibrillation (hazard ratio, 1.35 [95% CI, 1.05–1.73]; P=0.019), and Charlson comorbidity index (hazard ratio, 1.11 [95% CI, 1.05–1.18]; P=0.002) were associated with increased mortality. Aortic valve replacement was associated with better survival (hazard ratio, 0.38 [95% CI, 0.27–0.54]; P<0.001). CONCLUSIONS: The results of this study show that patients with MAS present many cardiovascular risk factors, a high rate of surgery during follow‐up, and increased mortality compared with the general population mainly related to associated comorbidities. Patients with MAS should, therefore, be managed for their cardiovascular risk factors and comorbidities. They require close follow‐up, especially when the aortic valve area is close to 1 cm(2), as aortic valve replacement performed when patients transition to severe AS and develop indications for surgery during follow‐up is associated with better survival. John Wiley and Sons Inc. 2019-03-07 /pmc/articles/PMC6475062/ /pubmed/30841771 http://dx.doi.org/10.1161/JAHA.118.011036 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Delesalle, Geraud
Bohbot, Yohann
Rusinaru, Dan
Delpierre, Quentin
Maréchaux, Sylvestre
Tribouilloy, Christophe
Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title_full Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title_fullStr Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title_full_unstemmed Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title_short Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
title_sort characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475062/
https://www.ncbi.nlm.nih.gov/pubmed/30841771
http://dx.doi.org/10.1161/JAHA.118.011036
work_keys_str_mv AT delesallegeraud characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction
AT bohbotyohann characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction
AT rusinarudan characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction
AT delpierrequentin characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction
AT marechauxsylvestre characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction
AT tribouilloychristophe characteristicsandprognosisofpatientswithmoderateaorticstenosisandpreservedleftventricularejectionfraction